Organizational efforts for Georgetown Lombardi Comprehensive Cancer Center (LCCC) clinical trials are focused at three sites: MedStar Georgetown University Hospital (MGUH) and MedStar Washington Hospital Center (MWHC) in Washington DC and the John Theurer Cancer Center (JTCC) in Hackensack, NJ. The JTCC Clinical Trials Office was added in 2014 after the 2013 signing of a Cancer Center Affiliation Agreement between LCCC and JTCC to work toward becoming a formal National Cancer Institute (NCI)?designated Consortium Cancer Center. The Clinical Research Management Office (CRMO) provides central management and oversight for coordinating, facilitating and reporting on LCCC clinical trials. CRMO Administrative Directors Radakovic (DC) and Richards (NJ) have extensive clinical research experience and report directly to the Medical Directors, Pishvaian (DC) and Goy (NJ) and through them to Giaccone, the Associate Director (AD) for Clinical Research. All are responsible for supervising personnel and procedures at their specific sites. The organization is supported by eight cross-institutional disease groups (DGs), which discuss, select and promulgate trial opportunities and employ a common Protocol Review and Monitoring System (PRMS). In addition, all investigator-initiated trials (IITs) are subject to oversight by a common Data Safety Monitoring Committee (DSMC). Within the CRMO, the Research Nursing and Data Management (RNDM) Offices are responsible for assigning, supervising and training the research nurses, study coordinators, data managers and lab technicians who staff therapeutic clinical trials. The Regulatory Management Office maintains regulatory binders for each protocol; submits protocols, amendments, annual reviews and adverse drug reaction reports to various regulatory authorities and maintains current copies of open protocols on a password-protected web site for investigators and staff. This effort has been greatly facilitated by the recent acquisition and implementation of a new Clinical Trials Management System (CTMS): OnCore Enterprise Research. The Quality Assurance Office (QAO) is responsible for compliance, monitoring activities and providing administrative and audit support to the DSMC. It also assists in staff training and educational activities. A recently formed Multi-Center Project Management Office is responsible for coordinating LCCC- led multisite IITs. Management teams for each site meet biweekly by conference call and quarterly in person to create joint standard operating procedures (SOPs). The Data Applications Group handles informatics, including the creation of electronic case report forms (eCRFs) for all IITs (now on OnCore) and maintenance of the OnCore database, which contains information about each protocol, to allow study submission to the NCI Clinical Trials Reporting Program (CTRP) for the generation of Data Table 4 and study-specific accrual reports. The DSMC is chaired by Dawson and oversees the NCI-approved plan.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-27
Application #
9924536
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
27
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
da Cruz, Raquel Santana; Carney, Elissa J; Clarke, Johan et al. (2018) Paternal malnutrition programs breast cancer risk and tumor metabolism in offspring. Breast Cancer Res 20:99
Fan, Ping; Tyagi, Amit K; Agboke, Fadeke A et al. (2018) Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cells. Cell Death Discov 4:15
Dash, Chiranjeev; Taylor, Teletia R; Makambi, Kepher H et al. (2018) Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: The FIERCE Study. Cancer 124:3355-3363
Lynce, Filipa; Blackburn, Matthew J; Cai, Ling et al. (2018) Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. Breast Cancer Res Treat 168:35-41
Paffhausen, Emily S; Alowais, Yasir; Chao, Cara W et al. (2018) Discovery of a stem-like multipotent cell fate. Am J Stem Cells 7:25-37
Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng et al. (2018) Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. PLoS One 13:e0192632
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Akinyemiju, Tomi F; Demb, Joshua; Izano, Monika A et al. (2018) The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review. Int J Public Health 63:787-797
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Furth, Priscilla A (2018) Peroxisome proliferator-activated receptor gamma and BRCA1. Endocr Relat Cancer :

Showing the most recent 10 out of 1120 publications